Funder
Deanship of Scientific Research
Prince Sattam bin Abdulaziz University
Academy of Finland
Sigrid Juselius Foundation
Caixa Foundation, Roviralta and Ubesol
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference36 articles.
1. WHO, World Health Organization, Leishmaniasis Fact sheet 375, Geneva, Switzerland, 2016.
2. Leishmaniasis;Pace;J. Infect.,2014
3. Leishmaniasis chemotherapy-challenges and opportunities;Croft;Clin. Microbiol. Infect.,2011
4. Drug resistance in leishmaniasis;Croft;Clin. Microbiol. Rev.,2006
5. Advances in structure-based drug discovery of carbonic anhydrase inhibitors;Supuran;Expert Opin. Drug Discov.,2017
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Computational evaluation of the inhibitory potential of some urea, thiourea, and selenourea derivatives of diselenides against leishmaniasis: 2D-QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation;Journal of Molecular Structure;2024-04
2. Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis;Journal of Biomolecular Structure and Dynamics;2023-11-08
3. Multi-protein targeting potential of some urea, thiourea, and selenourea derivatives of diselenides in leishmaniasis: molecular docking screening, oral bioavailability analysis, ADMET profiling, and molecular dynamics simulation;2023-11-08
4. Advances in the Development of Carbonic Anhydrase Inhibitors as
New Antiprotozoal Agents;Current Medicinal Chemistry;2023-10-31
5. First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome;Journal of Medicinal Chemistry;2023-07-12